世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

狂犬病予防接種の世界市場インサイト、2028年までの予測


Global Rabies Vaccination Market Insights, Forecast to 2028

狂犬病ワクチンは、動物に咬まれるなどして狂犬病ウイルスに感染した人を予防するために使用される免疫薬である。 市場の分析と洞察狂犬病予防接種の世界市場 COVID-19の大流行により、世界の狂犬病予防接種... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2022年6月17日 US$4,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

狂犬病ワクチンは、動物に咬まれるなどして狂犬病ウイルスに感染した人を予防するために使用される免疫薬である。

市場の分析と洞察狂犬病予防接種の世界市場
COVID-19の大流行により、世界の狂犬病予防接種市場規模は2022年に百万米ドル相当と推定され、2028年には予測期間2022-2028年にCAGR%で、百万米ドルの再調整サイズとなると予測されています。この健康危機による経済変化を十分に考慮し、2021年に狂犬病ワクチン世界市場の%を占めたベロ細胞は、2028年までに百万米ドルの価値を持ち、2022年から2028年まで修正された%のCAGRで成長すると予測されます。一方、曝露前セグメントは、この予測期間を通じて、% CAGRに変更されています。

中国の狂犬病予防接種の市場規模は2021年に百万米ドル、米国と欧州の狂犬病予防接種はそれぞれ百万米ドル、百万米ドルと評価されています。米国の比率は2021年に%、中国と欧州はそれぞれ%と%であり、中国の比率は2028年に%に達すると予測され、分析期間2022-2028年を通じてCAGRは%であると追跡しています。日本、韓国、東南アジアはアジアの注目すべき市場であり、今後6年間のCAGRはそれぞれ%、%、%である。ヨーロッパの狂犬病予防接種の展望については、ドイツは2028年までに100万米ドルに達すると予測され、予測期間2022年から2028年にかけてCAGR %を推移しています。
狂犬病予防接種の世界的な主要メーカーは、Bharat Biotech、Bavarian Nordic、Sanofi-Pasteur、Chengda Bio、KANGH、Prcmise、Henan Grand Biopharma、Zhuoyi Biological、ZhongKe Biopharmなどである。2021年、世界の上位5社は売上高で約 %のシェアを持つ。

世界の狂犬病予防接種の範囲とセグメント
狂犬病予防接種市場は、タイプ別と用途別に区分されます。世界の狂犬病予防接種市場におけるプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして利用することで、優位に立つことができるようになることでしょう。セグメント分析では、2017年から2028年までのタイプ別およびアプリケーション別の売上、収益、予測に焦点を当てています。

タイプ別セグメント
ベロ細胞
BHK
ニワトリ胚細胞
ヒト2倍体細胞
その他

用途別セグメント
曝露前
曝露後

会社別
バーラト・バイオテック
バイエルン・ノルディック
サノフィパスツール
成大バイオ
KANGH
プルミセ
河南大生物製薬
卓義バイオ
中科生物製剤
寧波栄源生物学有限公司
インディアン・イミュノロジカルズ

地域別
北アメリカ
米国
カナダ
欧州
ドイツ
フランス
英国
イタリア
ロシア
アジア太平洋地域
中国
日本
韓国
インド
オーストラリア
中国 台湾
インドネシア
タイ
マレーシア
中南米
メキシコ
ブラジル
アルゼンチン
中東・アフリカ
トルコ
サウジアラビア
UAE


ページTOPに戻る


目次

1 Study Coverage
1.1 Rabies Vaccination Product Introduction
1.2 Market by Type
1.2.1 Global Rabies Vaccination Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Vero Cell
1.2.3 BHK
1.2.4 Chick Embryo Cell
1.2.5 Human Diploid Cells
1.2.6 Others
1.3 Market by Application
1.3.1 Global Rabies Vaccination Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Pre-exposure
1.3.3 Post-exposure
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Rabies Vaccination Sales Estimates and Forecasts 2017-2028
2.2 Global Rabies Vaccination Revenue Estimates and Forecasts 2017-2028
2.3 Global Rabies Vaccination Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Rabies Vaccination Sales by Region
2.4.1 Global Rabies Vaccination Sales by Region (2017-2022)
2.4.2 Global Sales Rabies Vaccination by Region (2023-2028)
2.5 Global Rabies Vaccination Revenue by Region
2.5.1 Global Rabies Vaccination Revenue by Region (2017-2022)
2.5.2 Global Rabies Vaccination Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Rabies Vaccination Sales by Manufacturers
3.1.1 Global Top Rabies Vaccination Manufacturers by Sales (2017-2022)
3.1.2 Global Rabies Vaccination Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Rabies Vaccination in 2021
3.2 Global Rabies Vaccination Revenue by Manufacturers
3.2.1 Global Rabies Vaccination Revenue by Manufacturers (2017-2022)
3.2.2 Global Rabies Vaccination Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Rabies Vaccination Revenue in 2021
3.3 Global Rabies Vaccination Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Rabies Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Rabies Vaccination Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Rabies Vaccination Sales by Type
4.1.1 Global Rabies Vaccination Historical Sales by Type (2017-2022)
4.1.2 Global Rabies Vaccination Forecasted Sales by Type (2023-2028)
4.1.3 Global Rabies Vaccination Sales Market Share by Type (2017-2028)
4.2 Global Rabies Vaccination Revenue by Type
4.2.1 Global Rabies Vaccination Historical Revenue by Type (2017-2022)
4.2.2 Global Rabies Vaccination Forecasted Revenue by Type (2023-2028)
4.2.3 Global Rabies Vaccination Revenue Market Share by Type (2017-2028)
4.3 Global Rabies Vaccination Price by Type
4.3.1 Global Rabies Vaccination Price by Type (2017-2022)
4.3.2 Global Rabies Vaccination Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Rabies Vaccination Sales by Application
5.1.1 Global Rabies Vaccination Historical Sales by Application (2017-2022)
5.1.2 Global Rabies Vaccination Forecasted Sales by Application (2023-2028)
5.1.3 Global Rabies Vaccination Sales Market Share by Application (2017-2028)
5.2 Global Rabies Vaccination Revenue by Application
5.2.1 Global Rabies Vaccination Historical Revenue by Application (2017-2022)
5.2.2 Global Rabies Vaccination Forecasted Revenue by Application (2023-2028)
5.2.3 Global Rabies Vaccination Revenue Market Share by Application (2017-2028)
5.3 Global Rabies Vaccination Price by Application
5.3.1 Global Rabies Vaccination Price by Application (2017-2022)
5.3.2 Global Rabies Vaccination Price Forecast by Application (2023-2028)
6 North America
6.1 North America Rabies Vaccination Market Size by Type
6.1.1 North America Rabies Vaccination Sales by Type (2017-2028)
6.1.2 North America Rabies Vaccination Revenue by Type (2017-2028)
6.2 North America Rabies Vaccination Market Size by Application
6.2.1 North America Rabies Vaccination Sales by Application (2017-2028)
6.2.2 North America Rabies Vaccination Revenue by Application (2017-2028)
6.3 North America Rabies Vaccination Market Size by Country
6.3.1 North America Rabies Vaccination Sales by Country (2017-2028)
6.3.2 North America Rabies Vaccination Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Rabies Vaccination Market Size by Type
7.1.1 Europe Rabies Vaccination Sales by Type (2017-2028)
7.1.2 Europe Rabies Vaccination Revenue by Type (2017-2028)
7.2 Europe Rabies Vaccination Market Size by Application
7.2.1 Europe Rabies Vaccination Sales by Application (2017-2028)
7.2.2 Europe Rabies Vaccination Revenue by Application (2017-2028)
7.3 Europe Rabies Vaccination Market Size by Country
7.3.1 Europe Rabies Vaccination Sales by Country (2017-2028)
7.3.2 Europe Rabies Vaccination Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Rabies Vaccination Market Size by Type
8.1.1 Asia Pacific Rabies Vaccination Sales by Type (2017-2028)
8.1.2 Asia Pacific Rabies Vaccination Revenue by Type (2017-2028)
8.2 Asia Pacific Rabies Vaccination Market Size by Application
8.2.1 Asia Pacific Rabies Vaccination Sales by Application (2017-2028)
8.2.2 Asia Pacific Rabies Vaccination Revenue by Application (2017-2028)
8.3 Asia Pacific Rabies Vaccination Market Size by Region
8.3.1 Asia Pacific Rabies Vaccination Sales by Region (2017-2028)
8.3.2 Asia Pacific Rabies Vaccination Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Rabies Vaccination Market Size by Type
9.1.1 Latin America Rabies Vaccination Sales by Type (2017-2028)
9.1.2 Latin America Rabies Vaccination Revenue by Type (2017-2028)
9.2 Latin America Rabies Vaccination Market Size by Application
9.2.1 Latin America Rabies Vaccination Sales by Application (2017-2028)
9.2.2 Latin America Rabies Vaccination Revenue by Application (2017-2028)
9.3 Latin America Rabies Vaccination Market Size by Country
9.3.1 Latin America Rabies Vaccination Sales by Country (2017-2028)
9.3.2 Latin America Rabies Vaccination Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Rabies Vaccination Market Size by Type
10.1.1 Middle East and Africa Rabies Vaccination Sales by Type (2017-2028)
10.1.2 Middle East and Africa Rabies Vaccination Revenue by Type (2017-2028)
10.2 Middle East and Africa Rabies Vaccination Market Size by Application
10.2.1 Middle East and Africa Rabies Vaccination Sales by Application (2017-2028)
10.2.2 Middle East and Africa Rabies Vaccination Revenue by Application (2017-2028)
10.3 Middle East and Africa Rabies Vaccination Market Size by Country
10.3.1 Middle East and Africa Rabies Vaccination Sales by Country (2017-2028)
10.3.2 Middle East and Africa Rabies Vaccination Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Bharat Biotech
11.1.1 Bharat Biotech Corporation Information
11.1.2 Bharat Biotech Overview
11.1.3 Bharat Biotech Rabies Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Bharat Biotech Rabies Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bharat Biotech Recent Developments
11.2 Bavarian Nordic
11.2.1 Bavarian Nordic Corporation Information
11.2.2 Bavarian Nordic Overview
11.2.3 Bavarian Nordic Rabies Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Bavarian Nordic Rabies Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bavarian Nordic Recent Developments
11.3 Sanofi-Pasteur
11.3.1 Sanofi-Pasteur Corporation Information
11.3.2 Sanofi-Pasteur Overview
11.3.3 Sanofi-Pasteur Rabies Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Sanofi-Pasteur Rabies Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi-Pasteur Recent Developments
11.4 Chengda Bio
11.4.1 Chengda Bio Corporation Information
11.4.2 Chengda Bio Overview
11.4.3 Chengda Bio Rabies Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Chengda Bio Rabies Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Chengda Bio Recent Developments
11.5 KANGH
11.5.1 KANGH Corporation Information
11.5.2 KANGH Overview
11.5.3 KANGH Rabies Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 KANGH Rabies Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 KANGH Recent Developments
11.6 Prcmise
11.6.1 Prcmise Corporation Information
11.6.2 Prcmise Overview
11.6.3 Prcmise Rabies Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Prcmise Rabies Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Prcmise Recent Developments
11.7 Henan Grand Biopharma
11.7.1 Henan Grand Biopharma Corporation Information
11.7.2 Henan Grand Biopharma Overview
11.7.3 Henan Grand Biopharma Rabies Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Henan Grand Biopharma Rabies Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Henan Grand Biopharma Recent Developments
11.8 Zhuoyi Biological
11.8.1 Zhuoyi Biological Corporation Information
11.8.2 Zhuoyi Biological Overview
11.8.3 Zhuoyi Biological Rabies Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Zhuoyi Biological Rabies Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Zhuoyi Biological Recent Developments
11.9 ZhongKe Biopharm
11.9.1 ZhongKe Biopharm Corporation Information
11.9.2 ZhongKe Biopharm Overview
11.9.3 ZhongKe Biopharm Rabies Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 ZhongKe Biopharm Rabies Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 ZhongKe Biopharm Recent Developments
11.10 Ningbo Rongan Biological
11.10.1 Ningbo Rongan Biological Corporation Information
11.10.2 Ningbo Rongan Biological Overview
11.10.3 Ningbo Rongan Biological Rabies Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Ningbo Rongan Biological Rabies Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Ningbo Rongan Biological Recent Developments
11.11 Indian Immunologicals
11.11.1 Indian Immunologicals Corporation Information
11.11.2 Indian Immunologicals Overview
11.11.3 Indian Immunologicals Rabies Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Indian Immunologicals Rabies Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Indian Immunologicals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Rabies Vaccination Industry Chain Analysis
12.2 Rabies Vaccination Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Rabies Vaccination Production Mode & Process
12.4 Rabies Vaccination Sales and Marketing
12.4.1 Rabies Vaccination Sales Channels
12.4.2 Rabies Vaccination Distributors
12.5 Rabies Vaccination Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Rabies Vaccination Industry Trends
13.2 Rabies Vaccination Market Drivers
13.3 Rabies Vaccination Market Challenges
13.4 Rabies Vaccination Market Restraints
14 Key Findings in The Global Rabies Vaccination Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

 

ページTOPに戻る


 

Summary

Rabies Vaccine is an immunization drug used to prevent rabies in people who have been bitten by an animal or otherwise exposed to the rabies virus.

Market Analysis and Insights: Global Rabies Vaccination Market
Due to the COVID-19 pandemic, the global Rabies Vaccination market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Vero Cell accounting for % of the Rabies Vaccination global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Pre-exposure segment is altered to an % CAGR throughout this forecast period.

China Rabies Vaccination market size is valued at US$ million in 2021, while the US and Europe Rabies Vaccination are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Rabies Vaccination landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Rabies Vaccination include Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, Chengda Bio, KANGH, Prcmise, Henan Grand Biopharma, Zhuoyi Biological and ZhongKe Biopharm, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

Global Rabies Vaccination Scope and Segment
Rabies Vaccination market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Rabies Vaccination market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type
Vero Cell
BHK
Chick Embryo Cell
Human Diploid Cells
Others

Segment by Application
Pre-exposure
Post-exposure

By Company
Bharat Biotech
Bavarian Nordic
Sanofi-Pasteur
Chengda Bio
KANGH
Prcmise
Henan Grand Biopharma
Zhuoyi Biological
ZhongKe Biopharm
Ningbo Rongan Biological
Indian Immunologicals

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE



ページTOPに戻る


Table of Contents

1 Study Coverage
1.1 Rabies Vaccination Product Introduction
1.2 Market by Type
1.2.1 Global Rabies Vaccination Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Vero Cell
1.2.3 BHK
1.2.4 Chick Embryo Cell
1.2.5 Human Diploid Cells
1.2.6 Others
1.3 Market by Application
1.3.1 Global Rabies Vaccination Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Pre-exposure
1.3.3 Post-exposure
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Rabies Vaccination Sales Estimates and Forecasts 2017-2028
2.2 Global Rabies Vaccination Revenue Estimates and Forecasts 2017-2028
2.3 Global Rabies Vaccination Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Rabies Vaccination Sales by Region
2.4.1 Global Rabies Vaccination Sales by Region (2017-2022)
2.4.2 Global Sales Rabies Vaccination by Region (2023-2028)
2.5 Global Rabies Vaccination Revenue by Region
2.5.1 Global Rabies Vaccination Revenue by Region (2017-2022)
2.5.2 Global Rabies Vaccination Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Rabies Vaccination Sales by Manufacturers
3.1.1 Global Top Rabies Vaccination Manufacturers by Sales (2017-2022)
3.1.2 Global Rabies Vaccination Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Rabies Vaccination in 2021
3.2 Global Rabies Vaccination Revenue by Manufacturers
3.2.1 Global Rabies Vaccination Revenue by Manufacturers (2017-2022)
3.2.2 Global Rabies Vaccination Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Rabies Vaccination Revenue in 2021
3.3 Global Rabies Vaccination Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Rabies Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Rabies Vaccination Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Rabies Vaccination Sales by Type
4.1.1 Global Rabies Vaccination Historical Sales by Type (2017-2022)
4.1.2 Global Rabies Vaccination Forecasted Sales by Type (2023-2028)
4.1.3 Global Rabies Vaccination Sales Market Share by Type (2017-2028)
4.2 Global Rabies Vaccination Revenue by Type
4.2.1 Global Rabies Vaccination Historical Revenue by Type (2017-2022)
4.2.2 Global Rabies Vaccination Forecasted Revenue by Type (2023-2028)
4.2.3 Global Rabies Vaccination Revenue Market Share by Type (2017-2028)
4.3 Global Rabies Vaccination Price by Type
4.3.1 Global Rabies Vaccination Price by Type (2017-2022)
4.3.2 Global Rabies Vaccination Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Rabies Vaccination Sales by Application
5.1.1 Global Rabies Vaccination Historical Sales by Application (2017-2022)
5.1.2 Global Rabies Vaccination Forecasted Sales by Application (2023-2028)
5.1.3 Global Rabies Vaccination Sales Market Share by Application (2017-2028)
5.2 Global Rabies Vaccination Revenue by Application
5.2.1 Global Rabies Vaccination Historical Revenue by Application (2017-2022)
5.2.2 Global Rabies Vaccination Forecasted Revenue by Application (2023-2028)
5.2.3 Global Rabies Vaccination Revenue Market Share by Application (2017-2028)
5.3 Global Rabies Vaccination Price by Application
5.3.1 Global Rabies Vaccination Price by Application (2017-2022)
5.3.2 Global Rabies Vaccination Price Forecast by Application (2023-2028)
6 North America
6.1 North America Rabies Vaccination Market Size by Type
6.1.1 North America Rabies Vaccination Sales by Type (2017-2028)
6.1.2 North America Rabies Vaccination Revenue by Type (2017-2028)
6.2 North America Rabies Vaccination Market Size by Application
6.2.1 North America Rabies Vaccination Sales by Application (2017-2028)
6.2.2 North America Rabies Vaccination Revenue by Application (2017-2028)
6.3 North America Rabies Vaccination Market Size by Country
6.3.1 North America Rabies Vaccination Sales by Country (2017-2028)
6.3.2 North America Rabies Vaccination Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Rabies Vaccination Market Size by Type
7.1.1 Europe Rabies Vaccination Sales by Type (2017-2028)
7.1.2 Europe Rabies Vaccination Revenue by Type (2017-2028)
7.2 Europe Rabies Vaccination Market Size by Application
7.2.1 Europe Rabies Vaccination Sales by Application (2017-2028)
7.2.2 Europe Rabies Vaccination Revenue by Application (2017-2028)
7.3 Europe Rabies Vaccination Market Size by Country
7.3.1 Europe Rabies Vaccination Sales by Country (2017-2028)
7.3.2 Europe Rabies Vaccination Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Rabies Vaccination Market Size by Type
8.1.1 Asia Pacific Rabies Vaccination Sales by Type (2017-2028)
8.1.2 Asia Pacific Rabies Vaccination Revenue by Type (2017-2028)
8.2 Asia Pacific Rabies Vaccination Market Size by Application
8.2.1 Asia Pacific Rabies Vaccination Sales by Application (2017-2028)
8.2.2 Asia Pacific Rabies Vaccination Revenue by Application (2017-2028)
8.3 Asia Pacific Rabies Vaccination Market Size by Region
8.3.1 Asia Pacific Rabies Vaccination Sales by Region (2017-2028)
8.3.2 Asia Pacific Rabies Vaccination Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Rabies Vaccination Market Size by Type
9.1.1 Latin America Rabies Vaccination Sales by Type (2017-2028)
9.1.2 Latin America Rabies Vaccination Revenue by Type (2017-2028)
9.2 Latin America Rabies Vaccination Market Size by Application
9.2.1 Latin America Rabies Vaccination Sales by Application (2017-2028)
9.2.2 Latin America Rabies Vaccination Revenue by Application (2017-2028)
9.3 Latin America Rabies Vaccination Market Size by Country
9.3.1 Latin America Rabies Vaccination Sales by Country (2017-2028)
9.3.2 Latin America Rabies Vaccination Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Rabies Vaccination Market Size by Type
10.1.1 Middle East and Africa Rabies Vaccination Sales by Type (2017-2028)
10.1.2 Middle East and Africa Rabies Vaccination Revenue by Type (2017-2028)
10.2 Middle East and Africa Rabies Vaccination Market Size by Application
10.2.1 Middle East and Africa Rabies Vaccination Sales by Application (2017-2028)
10.2.2 Middle East and Africa Rabies Vaccination Revenue by Application (2017-2028)
10.3 Middle East and Africa Rabies Vaccination Market Size by Country
10.3.1 Middle East and Africa Rabies Vaccination Sales by Country (2017-2028)
10.3.2 Middle East and Africa Rabies Vaccination Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Bharat Biotech
11.1.1 Bharat Biotech Corporation Information
11.1.2 Bharat Biotech Overview
11.1.3 Bharat Biotech Rabies Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Bharat Biotech Rabies Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bharat Biotech Recent Developments
11.2 Bavarian Nordic
11.2.1 Bavarian Nordic Corporation Information
11.2.2 Bavarian Nordic Overview
11.2.3 Bavarian Nordic Rabies Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Bavarian Nordic Rabies Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bavarian Nordic Recent Developments
11.3 Sanofi-Pasteur
11.3.1 Sanofi-Pasteur Corporation Information
11.3.2 Sanofi-Pasteur Overview
11.3.3 Sanofi-Pasteur Rabies Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Sanofi-Pasteur Rabies Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi-Pasteur Recent Developments
11.4 Chengda Bio
11.4.1 Chengda Bio Corporation Information
11.4.2 Chengda Bio Overview
11.4.3 Chengda Bio Rabies Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Chengda Bio Rabies Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Chengda Bio Recent Developments
11.5 KANGH
11.5.1 KANGH Corporation Information
11.5.2 KANGH Overview
11.5.3 KANGH Rabies Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 KANGH Rabies Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 KANGH Recent Developments
11.6 Prcmise
11.6.1 Prcmise Corporation Information
11.6.2 Prcmise Overview
11.6.3 Prcmise Rabies Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Prcmise Rabies Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Prcmise Recent Developments
11.7 Henan Grand Biopharma
11.7.1 Henan Grand Biopharma Corporation Information
11.7.2 Henan Grand Biopharma Overview
11.7.3 Henan Grand Biopharma Rabies Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Henan Grand Biopharma Rabies Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Henan Grand Biopharma Recent Developments
11.8 Zhuoyi Biological
11.8.1 Zhuoyi Biological Corporation Information
11.8.2 Zhuoyi Biological Overview
11.8.3 Zhuoyi Biological Rabies Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Zhuoyi Biological Rabies Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Zhuoyi Biological Recent Developments
11.9 ZhongKe Biopharm
11.9.1 ZhongKe Biopharm Corporation Information
11.9.2 ZhongKe Biopharm Overview
11.9.3 ZhongKe Biopharm Rabies Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 ZhongKe Biopharm Rabies Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 ZhongKe Biopharm Recent Developments
11.10 Ningbo Rongan Biological
11.10.1 Ningbo Rongan Biological Corporation Information
11.10.2 Ningbo Rongan Biological Overview
11.10.3 Ningbo Rongan Biological Rabies Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Ningbo Rongan Biological Rabies Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Ningbo Rongan Biological Recent Developments
11.11 Indian Immunologicals
11.11.1 Indian Immunologicals Corporation Information
11.11.2 Indian Immunologicals Overview
11.11.3 Indian Immunologicals Rabies Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Indian Immunologicals Rabies Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Indian Immunologicals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Rabies Vaccination Industry Chain Analysis
12.2 Rabies Vaccination Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Rabies Vaccination Production Mode & Process
12.4 Rabies Vaccination Sales and Marketing
12.4.1 Rabies Vaccination Sales Channels
12.4.2 Rabies Vaccination Distributors
12.5 Rabies Vaccination Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Rabies Vaccination Industry Trends
13.2 Rabies Vaccination Market Drivers
13.3 Rabies Vaccination Market Challenges
13.4 Rabies Vaccination Market Restraints
14 Key Findings in The Global Rabies Vaccination Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/07 10:27

155.63 円

167.26 円

203.27 円

ページTOPに戻る